98 related articles for article (PubMed ID: 14728822)
1. Olmesartan inhibits the expression of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha and improves vascular remodeling after vascular injury in mouse.
Li Z; Chen XD; Ni SK; Li JW; Lin MS
Chin J Traumatol; 2004 Feb; 7(1):56-61. PubMed ID: 14728822
[TBL] [Abstract][Full Text] [Related]
2. Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan.
Jinno T; Iwai M; Li Z; Li JM; Liu HW; Cui TX; Rakugi H; Ogihara T; Horiuchi M
Hypertension; 2004 Feb; 43(2):263-9. PubMed ID: 14707152
[TBL] [Abstract][Full Text] [Related]
3. Effect of estrogen and AT1 receptor blocker on neointima formation.
Liu HW; Iwai M; Takeda-Matsubara Y; Wu L; Li JM; Okumura M; Cui TX; Horiuchi M
Hypertension; 2002 Oct; 40(4):451-7; discussion 448-50. PubMed ID: 12364346
[TBL] [Abstract][Full Text] [Related]
4. Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury.
Wu L; Iwai M; Nakagami H; Li Z; Chen R; Suzuki J; Akishita M; de Gasparo M; Horiuchi M
Circulation; 2001 Nov; 104(22):2716-21. PubMed ID: 11723025
[TBL] [Abstract][Full Text] [Related]
5. Soluble Flt-1 gene transfer ameliorates neointima formation after wire injury in flt-1 tyrosine kinase-deficient mice.
Koga J; Matoba T; Egashira K; Kubo M; Miyagawa M; Iwata E; Sueishi K; Shibuya M; Sunagawa K
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):458-64. PubMed ID: 19164801
[TBL] [Abstract][Full Text] [Related]
6. Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on vascular injury.
Chen R; Iwai M; Wu L; Suzuki J; Min LJ; Shiuchi T; Sugaya T; Liu HW; Cui TX; Horiuchi M
Hypertension; 2003 Oct; 42(4):542-7. PubMed ID: 12963679
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin inhibits release of tumor necrosis factor-alpha from human vascular smooth muscle cells.
Adkins JR; Castresana MR; Wang Z; Newman WH
Am Surg; 2004 May; 70(5):384-7; discussion 387-8. PubMed ID: 15156944
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effect of cerivastatin in vascular injury independent of serum cholesterol and blood pressure lowering effects in mouse model.
Chen X; Li Z; Li J
Chin J Traumatol; 2002 Oct; 5(5):294-8. PubMed ID: 12241641
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of monocyte chemoattractant protein-1 expression via inhibition of nuclear factor-kappaB activity in inflammatory vascular injury.
Gao X; Iwai M; Inaba S; Tomono Y; Kanno H; Mogi M; Horiuchi M
Am J Hypertens; 2007 Nov; 20(11):1170-5. PubMed ID: 17954363
[TBL] [Abstract][Full Text] [Related]
10. Prevention of vascular injury by combination of an AT1 receptor blocker, olmesartan, with various calcium antagonists.
Inaba S; Iwai M; Tomono Y; Senba I; Furuno M; Kanno H; Okayama H; Mogi M; Higaki J; Horiuchi M
Am J Hypertens; 2009 Feb; 22(2):145-50. PubMed ID: 19057515
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin promotes the expression of monocyte chemoattractant protein-1 in vascular myocytes and mediates vascular inflammation.
Satonaka H; Suzuki E; Nishimatsu H; Oba S; Takeda R; Goto A; Omata M; Fujita T; Nagai R; Hirata Y
Circ Res; 2004 Mar; 94(5):693-700. PubMed ID: 14739159
[TBL] [Abstract][Full Text] [Related]
12. PTEN reduces cuff-induced neointima formation and proinflammatory cytokines.
Koide S; Okazaki M; Tamura M; Ozumi K; Takatsu H; Kamezaki F; Tanimoto A; Tasaki H; Sasaguri Y; Nakashima Y; Otsuji Y
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2824-31. PubMed ID: 17277022
[TBL] [Abstract][Full Text] [Related]
13. Effect of olmesartan medoxomil on atherosclerosis: clinical implications of the emerging evidence.
Takai S; Miyazaki M
Am J Cardiovasc Drugs; 2006; 6(6):363-6. PubMed ID: 17192125
[TBL] [Abstract][Full Text] [Related]
14. The effect of olmesartan on aortic intimal thickening after balloon injury through Apelin/APJ.
Li Y; Guo J; Yu H; Zhou J; Chu X; Hou B; Ge J; Li T; Duan S; Xu H; Yang X
Cardiovasc Pathol; 2020; 49():107230. PubMed ID: 32585603
[TBL] [Abstract][Full Text] [Related]
15. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
[TBL] [Abstract][Full Text] [Related]
16. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.
Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS
J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197
[TBL] [Abstract][Full Text] [Related]
17. Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling.
Zhao Q; Ishibashi M; Hiasa K; Tan C; Takeshita A; Egashira K
Hypertension; 2004 Sep; 44(3):264-70. PubMed ID: 15262905
[TBL] [Abstract][Full Text] [Related]
18. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
[TBL] [Abstract][Full Text] [Related]
19. Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation.
Pires NM; Pols TW; de Vries MR; van Tiel CM; Bonta PI; Vos M; Arkenbout EK; Pannekoek H; Jukema JW; Quax PH; de Vries CJ
Circulation; 2007 Jan; 115(4):493-500. PubMed ID: 17242285
[TBL] [Abstract][Full Text] [Related]
20. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling.
Ishibashi M; Hiasa K; Zhao Q; Inoue S; Ohtani K; Kitamoto S; Tsuchihashi M; Sugaya T; Charo IF; Kura S; Tsuzuki T; Ishibashi T; Takeshita A; Egashira K
Circ Res; 2004 May; 94(9):1203-10. PubMed ID: 15059935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
